National Center for Tumor Diseases (NCT) Heidelberg
Nektarios (Nek) Valous serves as a Senior Research Associate at the National Center for Tumor Diseases Heidelberg since October 2013, while also acting as the founding and executive editor for the peer-reviewed journal ImmunoInformatics at Elsevier since October 2020. Previously, Nektarios held research and lecturer positions at various institutions including UniversitätsKlinikum Heidelberg, Universität Heidelberg, and University College Dublin. Nektarios began research career as an assistant at Aristotle University of Thessaloniki and has experience in consulting roles at the Central Institute for Supervising & Testing in Agriculture and the Czech Agriculture & Food Inspection Authority. Nektarios obtained a Doctorate in Philosophy from University College Dublin, along with multiple advanced degrees and certifications from reputable institutions such as The Open University and Harvard Medical School.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.